《结肠癌二期辅助化疗图文课件》由会员分享，可在线阅读，更多相关《结肠癌二期辅助化疗图文课件（18页珍藏版）》请在金锄头文库上搜索。
1、0河仁俊L2Anomicstogoroonostccroups3ooeDDokes,MAc*TiMo-?口NaMo仁团史NeM义8H&ENeMoB82HTdaNaMo882HicT4bNM日3HATi-T2NWiicMocciTNaaMo5c丨iteT3iTiaNVtcMo团c2EaMQSic7TN2b伟5cI24EHczT3TaaNabMocc2TabNMoCGAAnyTAnyNMia5INBAnyTAnyNMibMNeecemoyis余cincaldasijicstonpmdiishpatiogecossmaeonTeyrefxisusedinIosecancershatanscessii
2、edsfernecadiovenipeeeapnentiegJpTNMJPatentsaveacenpetspaeologcaponeareypTONOcMOetmeybesmianieSupeeupporlTherprefristobeunedlorpocecancensstveecunedstarsdosoeeeercadfN“DoezBisacompostefbeterfT3HMOJsndverseITiNOMQJpmgrostegoups驱旯DokssCiAnyTNIMOandAnyTN2MOJMACisinemoaedecColerdanafcnionnnColonCancer.Co
3、mprhenseNCCNGuidelinesVersion2.2016NervodeSuRVEILColonostMfadvsfnoa期沥沥刀History(Ms|NordMMR)0enevCHnicaltnal.CEAKenTaNoMowBisatoalc(MSHLorMsSand一一|0proratonChesterohighriekConsiderspeciabiiep。0lorfUheucovonmpn“ColonotCapestabinepa。一colonosEFUeucovonnpcelonosifadvsTaNOMoathighrigkforRDuroxeparorcapeoxp
4、ara_e+Wnoasystemicecurrencer0m|一e|orFLOXparateveryEorPETCTChnicaltal一一一*SeePHodeposttvedisease,orCompanyLeg5全MS(microsate11ite,微卫星)基因组中小于10个核苷酸的简单重复的DNA序列栗MS1(microsate11iteinstabi1ity,微卫星不稳定)由于DNA修复错误导致微卫星的丢失或增加*MSI-H,微卫星高频不稳定*MSI-L,像卫星低频不稳定*MSS,微卫星稳定全MNR(mismatchedrepai错配修复基因,一股检测相关蛋白*dMMR,错配修复蛎白缺
5、失*pMMR,错配修复蛎白正常怀MSI-H相当于qNMR;MSI-L/MSS相当于pMMRSogenipJialalJCinoneslznititazlgduas本研究检测5项RCT,457例患者;2大数据库,1027例感者未辅助化疗患者接受辅助化疗患者100志怪s|口|。一L一谢搜601,17SAUI伟仰一ao题HR=051题HR=07995W%Cls0.29-0.89E芸50P-0009木56P-030一dMMR(n=79)一dMMRn=86)一pMMR(n=436)一pMMR(n=426)012345012345刑闭(绍)刑闽(绍)SooenipjalaJCinonealzoiti3sa
6、zl8305IRENSHGNNRGNSSHSIL飞嚏E王HR=230HR=0.4郎95W%Cic0.84-62450|gssclc0.57-1.24P=0.09P-028槛吊I朋堰b巳BdWMR,山标pMMR2020一邑8)ft疗-55)一Xn-219一PU辆B化疗c47)一P辐助化疗(n214)01应一01口明间(绍)明间卵)如果只考虑氟尿嘌啶类治疗,必须考虑患者的MMR状忘Sooen0I翠MSIH患者预后较好旦不能从5FU辅助化疗中获益pmgCISgme高危II期患者一修改说明NCCNGuldelnesVersion3.2013ColonCancerestngformismatchrepa
7、irproteins(MMRJshoukbeconsideredforallpatients50yearsofage.StagelMSHHpatentsmayhaveagoodprognosisanddonotbeneftfrom5-FUaduvantherapy.SargentDJ,MarsoniS,MongesG,etalDefectivemismatchrepairasapredictvemarkerforlackofeffcacyoffiuorouraci-basedadivantherapyincoloncancer.JCinOncol2010;28;3219-3226Avaliab
8、leathttoyhnnwncbinimnihaovpubmed2049003roooerr-eemayemasammrnaag日2Dnc-Efosing-:7T江TJioer5070ToCosneig办Pieng0cfage0Wistag*川d3e58e58deMSLHadentsriaynavea00dprognosis2nd00neteneftfom5-FUadivantiherapySargentDJMarsoniSMongesGetaLDefecivemismatchrepairasapredicivemerkeriorlackofeifcaeyoffyorouraci-bsseda
9、duvantterapyinc0loncancer.JCinOncol2010:28:3219.3226.Availableathanowncbinmnhaovloubredl2n93nE心d朋可能预后良好,东些不能从5-FU辅助治疗中获益I期MSLH意者hcocimealpneteecudstnesinonesegzcsoncenceeVazoNCCNGuidelinesVersion2.2016ColonCancerrouoocsmaeApuovurrveeresumweuwteermymgmrmeacrmparmmmoemsergts所余fforanmngzrysar仁|ofageorw
10、ihstageldisease.StageIMSLHpatentsmayhaveagoodprognosisanddo|notbeneftfomSFUaduvantherapy.SargentDJMarsoniSMongesG,etsl.Defectvemiematchrepairas5preticvemarkeriorlsckfsiicaeyaffuerouraelhbasedaduvant人herapyinceloncancerJCinOncel2010;28.3219.3226.SeePnaiplesIc-MicrosetefiteInstabiiyy(MSI)orMismatchRep
11、air(MMRJfestngloLynchSvndromeL1FmTyocrmopeanu|-css口neonieG亢losnie|urecosiercmeoean-诚洁sneneaninct日agE万国刑pnvreriyniecpneneedhedcmgodoeanePcsmmemusessmemESooermnon-国的检测。具有MSI-H(高度微卫星不稳定)的I期患者可能预后较好,日不会从5-FU的辅助治疗中获盐。CompanyLogoColonCancer*NCCNGuidellnesVersion3.2013NCCN2013V3,绣矿0LFo的“尤选臭neuaax一命n|tinrad
12、systemicrecurrenceloiorT4N0,M0NodeposltvediseaseseepageCOL4T3,N0,M0athighriskforsystemicrecurrencelxlorT4,N0,M0从“如选择含奠沙利钳方案,改为hcocimealpaeteecudstnesinonesegzcsoncenceeVazo5FUfieucovorln2p土oxaliplatn28一一一FOLFOXorFLOX9orCapecabine25土qxaliplatinop一FCLFOXpreferredidxaliplatinbasedregmenusedorClinicaltr
13、iaorObservation一颂n一医Capecitabine24or5-FUleucovorineFOLFOXaparorCapeOxapadorFLOXP4re则优选FOLFOX“FOLFOX/CAPEOX/FLOX“stceadConpimmtNCCNGuidelinesVersion2.2016ConeCouncnntsalCntet4ColonCancerDeasumouoecsmeeuuwurTeuer。sbmveuwcercoesreoryatlE余en友版吴AneeaenensgreysrMyWooonomeoveegztootnayferauunnnsiesieeliadsyLcEyany2tmoioriyhneeneneEEEeniesund医2na英esetcye河阮。1reegredn许标1eaonesioteoennrmoingyJneagyendniinonsnpoatinayunTsnEi2余Inoyneeneean5nECompanyLeg5
